A treatment option for patients with mesothelioma cancer has recently been evaluated at a medical conference in Europe. A surgical procedure known as pleurectomy / decortication, which involves the removal of the outermost regions lining of the lungs, is intended for patients suffering from malignant mesothelioma.
According to a study presented at the 2009 European Multidisciplinary Conference in Thoracic Oncology, surgery was considered successful when chemotherapy preceded and was used as part of a three-pronged approach to treatment with radiation therapy.
The study was prepared by a group of experts in the treatment of mesothelioma to validate the effectiveness of pleurectomy / decortication other surgical procedure: pneumonectomy, the medical term for the removal of a lung.
Malignant mesothelioma is a rare cancer caused almost exclusively by exposure to asbestos. Due to a long latency period, patients often develop symptoms of mesothelioma several decades after initial exposure.
Mesothelioma patients are often advised by doctors to carry out multiple forms of treatment for both have the greatest chance of survival. A popular treatment combination ALIMTA implies a type of chemotherapy after surgery resectable.
For this study, thirty-five patients with malignant pleural mesothelioma were observed over a period of five years from November 2002 to October 2007. The patients underwent the pleurectomy / decortications procedure for four sessions of chemotherapy and radiation to the chest wall and thorax.
Approximately 94 percent of patients completed the treatment regimen. One year survival rate was 75 percent survival rate at two years was 61 percent, and the survival rate was reported in three years 43 per cent.
The researchers believe that further study, but pleurectomy / decortication demonstrate that the positive results of survival. Here in the United States, what oncologists like Dr. Carrie Redlich of Yale University, are working to find a cure for this devastating disease. [Source]
According to a study presented at the 2009 European Multidisciplinary Conference in Thoracic Oncology, surgery was considered successful when chemotherapy preceded and was used as part of a three-pronged approach to treatment with radiation therapy.
The study was prepared by a group of experts in the treatment of mesothelioma to validate the effectiveness of pleurectomy / decortication other surgical procedure: pneumonectomy, the medical term for the removal of a lung.
Malignant mesothelioma is a rare cancer caused almost exclusively by exposure to asbestos. Due to a long latency period, patients often develop symptoms of mesothelioma several decades after initial exposure.
Mesothelioma patients are often advised by doctors to carry out multiple forms of treatment for both have the greatest chance of survival. A popular treatment combination ALIMTA implies a type of chemotherapy after surgery resectable.
For this study, thirty-five patients with malignant pleural mesothelioma were observed over a period of five years from November 2002 to October 2007. The patients underwent the pleurectomy / decortications procedure for four sessions of chemotherapy and radiation to the chest wall and thorax.
Approximately 94 percent of patients completed the treatment regimen. One year survival rate was 75 percent survival rate at two years was 61 percent, and the survival rate was reported in three years 43 per cent.
The researchers believe that further study, but pleurectomy / decortication demonstrate that the positive results of survival. Here in the United States, what oncologists like Dr. Carrie Redlich of Yale University, are working to find a cure for this devastating disease. [Source]
